Corporate News 16-Mar-23
Eris Lifesciences to acquire 9 dermatology brands from Dr Reddys
Eris Lifesciences is acquiring nine dermatology brands from Dr. Reddy's Laboratories for Rs 275 crore. The transaction is expected to close on or before 31 March 2023.
Previous News
Dr Reddys Laboratories Ltd spurts 1.14%, up for third straight session
( Hot Pursuit - 04-Jul-24 13:05 )
Zydus and Dr Reddy's ink licensing agreement to co-market Pertuzumab in India
( Corporate News - 28-Jun-24 19:04 )
Indices trade with minor gains; European mkt opens higher
( Market Commentary - Mid-Session 28-Jun-24 13:44 )
Market hits new life high; IT shares advance
( Market Commentary - Mid-Session 27-Jun-24 12:43 )
Dr Reddy’s Lab jumps after arm inks pact to acquire Nicotinell brand
( Hot Pursuit - 27-Jun-24 11:05 )
Dr Reddys Laboratories Ltd gains for fifth session
( Hot Pursuit - 26-Jun-24 13:00 )
Eris Lifesciences allots 22,492 equity shares under ESOP
( Corporate News - 24-Jun-24 12:26 )
Dr Reddys Laboratories to conduct board meeting
( Corporate News - 21-Jun-24 17:07 )
LIC hikes stake in Dr Reddy's
( Corporate News - 13-Jun-24 20:38 )
Sensex, Nifty hit fresh record high; realty shares rally; VIX drops 6.25%
( Market Commentary - Quick Review 13-Jun-24 15:44 )
Dr Reddy’s arm inks pact with Ingenus Pharma to market Cyclophosphamide Injection
( Hot Pursuit - 13-Jun-24 12:18 )
Other Stories
High Energy Batteries (India) to discuss results
06-Jul-24 10:29
Havells India schedules board meeting
06-Jul-24 10:29
Axis Bank announces board meeting date
06-Jul-24 10:29
Mastek to conduct board meeting
06-Jul-24 10:29
Oriental Hotels to conduct board meeting
06-Jul-24 10:29
Milkfood schedules AGM
06-Jul-24 10:28
Transcorp International to table results
06-Jul-24 10:28
MRP Agro to convene board meeting
06-Jul-24 10:28
Thirumalai Chemicals to table results
06-Jul-24 10:28
Bajaj Healthcare schedules board meeting
06-Jul-24 10:27
Back
Top